Technology | June 29, 2006

System Addresses Demand for Defibrillation Energy

Guidant Corp.’s VITALITY HE implantable cardioverter defibrillator combines the small, physiologic profile and exceptional longevity with the capacity to deliver more energy to defibrillate the patient. It also provides excellent diagnostics and fast charge times.
The VITALITY HE offers the advanced functionality of the VITALITY family. Recent usage data suggest that more than half of conventional defibrillators implanted in the U.S. today have higher energy output capability.


Additional Content

News | Implantable Cardioverter Defibrillator (ICD)

Jan. 12, 202 — Abbott and AtaCor Medical have announced a collaboration to advance a next-generation investigational ...

Home January 13, 2026
Home
News | Implantable Cardioverter Defibrillator (ICD)

Sept. 16, 2025 — Elutia Inc., a pioneer in drug-eluting biomatrix technologies, has published clinical and preclinical ...

Home September 19, 2025
Home
News | Implantable Cardioverter Defibrillator (ICD)

Sept. 2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter ...

Home September 05, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
Subscribe Now